InsiderClue
Insiders · Profile

Atlas Venture Fund IX, L.P.

10% owner at Cogent Biosciences · 10% owner at Intellia Therapeutics. Filing since 7 Jul 2017. CIK 0001671219

COGT Cogent Biosciences, Inc. 10% owner · 1 trade NTLA Intellia Therapeutics, Inc. 10% owner · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
COGT Cogent Biosciences, Inc.
3 Apr 2018
10% owner
Bought
94,052
$1.13M
2.9%
NTLA Intellia Therapeutics, Inc.
11 Jul 2017
10% owner
Sold, plan not stated
80,000
$1.29M
2.2%
NTLA Intellia Therapeutics, Inc.
10 Jul 2017
10% owner
Sold, plan not stated
40,000
$646.89K
1.1%
NTLA Intellia Therapeutics, Inc.
7 Jul 2017
10% owner
Sold, plan not stated
30,000
$502.99K
0.8%
4 decisions on file.